This report provides an update on national progress in meeting the goals of the National HIV/AIDS Strategy (2022-2025) based on the most current available data and also highlights some recent federal efforts to implement the Strategy.
In this podcast episode, Anousha and Bright invited Dr. Robert Gish to speak about hepatitis B Reactivation, a serious health issue often overlooked in the discourse surrounding hepatitis B and liver cancer.
More than 2.4 million cases of chlamydia, gonorrhea, and syphilis were reported in the U.S. in 2023. Still, the numbers show the cases of reportable STIs tended to decrease, or at least saw a sharp decline in the rate by which they increased. In this episode of the Sex+Health podcast, we talk with Bradley Stoner, MD, PhD, the Director of the Centers for Disease Control and Prevention Division of STD Prevention, for his thoughts on what's driving the epidemic and why the latest data show there may be cause for optimism.
Contact organization for eligibility
Contact organization for eligibility
Reported Tuberculosis in the United States, 2023 provides the most current and complete data for tuberculosis in the U.S.
Sexually Transmitted Infections Surveillance, 2023 provides the most current and complete data for three nationally notifiable STIs: chlamydia, gonorrhea, and syphilis, including congenital syphilis.
NASTAD highlights the achievements of the 47 Ending the HIV Epidemic (EHE) Phase 1 jurisdictions through a series of success stories featured on a dedicated webpage. These stories demonstrate innovative strategies addressing the four pillars of EHE: Diagnose, Treat, Prevent, and Respond. Supported by the Health Resources and Services Administration (HRSA), this initiative aims to strengthen programs for individuals living with and at risk for HIV.
Contact organization for eligibility
Contact organization for eligibility
